Showing results (431-440 of 1,188) with videos related to
Sort By:
Pageof 119
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2004
Dose-dependent response of FGF-2 for lymphangiogenesisLynn K Chang, Guillermo Garcia-Cardeña, Filip Farnebo, et al.American Journal of Hematology|November 20, 2014
Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibodyElias Jabbour, Susan O'Brien, Xuelin Huang, et al.Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune CheckpointsJuliana E Hidalgo-López, Rashmi Kanagal-Shamanna, Andrés E Quesada, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancersFadi Braiteh, Andres O Soriano, Guillermo Garcia-Manero, et al.Cancer|January 20, 2007
Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemiaYasuhiro Oki, Hagop M Kantarjian, Vazganush Gharibyan, et al.Cancer|February 23, 2007
Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experienceHagop M Kantarjian, Susan O'Brien, Xuelin Huang, et al.Cancer|May 12, 2006
Activity of alemtuzumab in patients with CD52-positive acute leukemiaRaoul Tibes, Michael J Keating, Alessandra Ferrajoli, et al.Leukemia & Lymphoma|May 7, 2015
Analysis of class I and II histone deacetylase gene expression in human leukemiaHui Yang, Sirisha Maddipoti, Andres Quesada, et al.Cureus|January 26, 2026
Navigating the Crisis of White Cord Syndrome in a Diabetic Female Patient After Cervical Spine Surgery: A Case ReportHarold L Rivera-Alvarado, Guillermo Garcia-Vargas, Julián J Zayas-Vélez, et al.Cancer|December 7, 2005
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaDeborah A Thomas, Andreas H Sarris, Jorge Cortes, et al.Pageof 119